EUVIMED · CrossrefZeitschrift
Fibrinolysis
ISSN 0268-9499 · Elsevier BV
Neueste Artikel
Characterisation of rt-PA I276G, a recombinant human tissue-type plasminogen activator mutant with altered plasmin cleavage site
Comparative fibrinolytic and fibrinogenolytic properties of staphylokinase and streptokinase in plasma of different species in vitro
One chain variants of tissue plasminogen activator have increased susceptibility to inactivation by plasmin
Plasmin-catalysed cleavage of single chain tissue-type plasminogen activator in fibrin clots
The sequential, complementary and synergistic activation of fibrin-bound plasminogen by tissue plasminogen activator and pro-urokinase
A monoclonal antibody to tissue plasminogen activator with affinity for the Kringle regions
Relation of fibrin and tumour-associated antigens to the spread of ovarian cancer
Survival of fibrinogen degradation products in the circulation after thrombolytic therapy for acute myocardial infarction
Myocardial tissue salvage by coronary thrombolysis with rt-PA: Absence of occlusion/reperfusion injury
A new kit for the determination of tissue plasminogen activator and its inhibitor in blood
Thrombolytic effect of pro-urokinase in vitro
The typical staccato phenomenon of myoglobin in acute myocardial infarction disappears under thrombolytic treatment
Characterisation of fibronectin fragments and plasminogen activators released by RSV-transformed cells
Plasminogen activator activity of human plasma and transformed cells conditioned media: Dependence on divalent cations
Fibrinolytic response in malignancy
Notices
On the relationship between different molecular forms of the fast inhibitor of tissue plasminogen activator
Biological properties of a kringleless tissue plasminogen activator (t-PA) mutant
Functional measurement of t-PA in plasma using a bead immuno chromogenic assay (BICA)
Amino acid sequence of the heavy chain of porcine plasmin. Comparison of the carbohydrate attachment sites with the human and bovine species
Increased tissue plasminogen activator expression by epithelial cell lines treated with lectins
Regulation of plasminogen activator and plasminogen activator-inhibitor production by tissue culture cells: Evidence for independent induction and regulation
Fibrinolytic activity in the healthy newborn infant at term
Experimental fibrinolytic therapy of localised microthrombosis
A direct cbromogenic peptide substrate assay for hageman factor (FXII)
Release of plasminogen activator and stimulation of platelets by stable analogues of platelet activating factor (PAF)
XIth Congress of the International Society on Thrombosis and Haemostasis
Editorial Board
Editorial
International Committee for Fibrinolysis—Kabi Prize Lecture 1986
EUVIMED